Humana has agreed to sell its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valued at approximately $900 million.

Details of the Sale

The stake will be sold to a group of investors, with Humana planning to use the proceeds for general corporate purposes. The deal is not expected to affect Humana’s 2026 earnings.

Gentiva provides hospice care and support for seriously ill patients at over 430 locations in 35 states. Humana’s stake in Gentiva stems from its 2021 Kindred at Home deal, after which it announced plans to sell non-core hospice and personal care businesses.

In 2022, Humana sold a majority stake in Kindred at Home’s hospice and personal care units to private equity firm Clayton, Dubilier & Rice. The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals and other closing conditions.

Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.